drugset / Trial / NCT00121953
Effect of Rosiglitazone on Peritoneal Cytokines in Women With Endometriosis
Phase 2/3
Withdrawn
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
RandomizedParallel-groupDouble-blindDiagnostic
Summary
The purpose of this study is to compare the effect of rosiglitazone versus placebo on soluble proinflammatory markers in peritoneal fluid of women with endometriosis.
Timeline
- Start
- 2005-07
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosiglitazone | Small molecule | 4 mg | — |